We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations (IMPACT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03570619
Recruitment Status : Active, not recruiting
First Posted : June 27, 2018
Last Update Posted : August 4, 2022
Memorial Sloan Kettering Cancer Center
University of California, San Francisco
Information provided by (Responsible Party):
University of Michigan Rogel Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : May 2023
Estimated Study Completion Date : May 2023